selected
Projects
Turkish Hypertension Consensus Report (2019)
The Turkish Hypertension Consensus Report was prepared in cooperation with Turkish Society of Cardiology, Turkish Society of Internal Medicine, Turkey Society of Endocrinology and Metabolism, Turkish Society of Nephrology, and Turkish Society of Hypertension and Renal Diseases and published in 2019.
Turkish Hypertension Consensus Report (2015)
The Turkish Hypertension Consensus Report was prepared in cooperation with Turkish Society of Cardiology, Turkish Society of Internal Medicine, Turkey Society of Endocrinology and Metabolism, Turkish Society of Nephrology, and Turkish Society of Hypertension and Renal Diseases and was published in 2019.
Turkish Lung Cancer Roadmap
Turkish Lung Cancer Roadmap was prepared in cooperation with Turkish Society of Medical Oncology, Turkish Immuno-Oncology Society, Turkish Thoracic Society and Turkish Society of Lung Cancer and was published in 2017.
Turkey Melanoma Roadmap
Turkey Melanoma Roadmap was prepared in cooperation with Ministry of Health Head Department of Cancer and Turkish Oncology Group and was published in 2015.
Turkey Viral Hepatitis Prevention and Control Program
Turkey Viral Hepatitis Prevention and Control Program was prepared in cooperation with Ministry of Health Public Health Institution, Viral Hepatitis Society, Turkish Liver Research Association and Hepato-Bilio-Pancreatology Association and was published in 2016.
Hepatit B Roadmap
Hepatit B Roadmap was prepared in cooperation with Turkish Liver Research Association and was published in 2014.
Model Adaptation for Reimbursement File
Leuprorelin; Prostate cancer.
Model Adaptation for Reimbursement File
İpilimumab; Metastatic Malignant Melanoma
Model Adaptation for Reimbursement File
Ticagrelor; Myocardial Infarction
Model Adaptation for Reimbursement File
Gefitinib; Non-Small Cell Lung Cancer
Model Adaptation for Reimbursement File
Osimertinib; Non-Small Cell Lung Cancer
Model Adaptation for Reimbursement File
Nivolumab; Metastatic Malignant Melanoma
Model Adaptation for Reimbursement File
Afatinib; Non-Small Cell Lung Cancer
Model Adaptation for Reimbursement File
Afatinib; Small Cell Lung Cancer
Model Adaptation for Reimbursement File
Nintedanib; Idiopathic Pulmonary Fibrosis
Model Adaptation for Reimbursement File
Idarucizumab; Bleeding control
Model Adaptation for Reimbursement File
Nivolumab; Metastatic Renal Cell Carcinoma
Model Adaptation for Reimbursement File
Nivolumab; Classic Hodgkin’s Lymphoma
Model Adaptation for Reimbursement File
Mifamurtid; Osteosarcoma
Model Adaptation for Reimbursement File
Brigatinib; Non-Small Cell Lung Cancer
Model Adaptation for Reimbursement File
Sorafenib; Metastatic Hepatocellular Carcinoma
Model Adaptation for Reimbursement File
Nilotinib; Philadelphia chromosome positive chronic myeloid leukemia
Model Adaptation for Reimbursement File
The combination of dabrafenib + trametinib; BRAF V600 mutation positive Metastatic Melanoma
Model Adaptation for Reimbursement File
Nivolumab; Metastatic Head and Neck Cancer
Model Adaptation for Reimbursement File
Nivolumab; Adjuvant Malignant Melanoma
Model Adaptation for Reimbursement File
Besifloxacin; Bacterial Conjunctivitis
Model Adaptation for Reimbursement File
Nivolumab; Metastatic Flat Cell Non-Small Cell Lung Cancer
Model Adaptation for Reimbursement File
Pre-implantation genetic screening
Model Adaptation for Reimbursement File
Nivolumab; Non-metastatic Non-squamous Cell Small Lung Cancer